Cite

HARVARD Citation

    Ishitsuka, K. et al. (n.d.). A phase II study of bortezomib in patients with relapsed or refractory aggressive adult T‐cell leukemia/lymphoma. Cancer science. 106 (9), pp. 1219-1223. [Online]. 
  
Back to record